<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="article-commentary">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title>Frontiers in Genetics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Genet.</abbrev-journal-title>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fgene.2017.00135</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>General Commentary</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Commentary: Grand challenge: ELSI in a changing global environment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Macpherson</surname> <given-names>Ignacio</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/432278/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Segarra</surname> <given-names>Ignacio</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/332338/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Humanities, International University of Catalonia</institution>, <addr-line>Barcelona</addr-line>, <country>Spain</country></aff>
<aff id="aff2"><sup>2</sup><institution>School of Pharmacy, University of Barcelona</institution>, <addr-line>Barcelona</addr-line>, <country>Spain</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Go Yoshizawa, Osaka University, Japan</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Federico Gustavo Pizzetti, Universit&#x000E0; degli Studi di Milano, Italy</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Ignacio Macpherson <email>imacpherson&#x00040;gmail.com</email></p></fn>
<fn fn-type="other" id="fn002"><p>This article was submitted to ELSI in Science and Genetics, a section of the journal Frontiers in Genetics</p></fn></author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>09</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>135</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>07</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>09</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Macpherson and Segarra.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Macpherson and Segarra</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front Genet" journal-id-type="nlm-ta" vol="4" page="158" xlink:href="23990842" ext-link-type="pubmed">A commentary on <article-title>Grand challenge: ELSI in a changing global environment</article-title> by Greenbaum, D. (2013). Front. Genet. 4:158. doi: <object-id>10.3389/fgene.2013.00158</object-id></related-article>
<kwd-group>
<kwd>ELSI</kwd>
<kwd>human enhancement</kwd>
<kwd>genomic</kwd>
<kwd>bioethics</kwd>
<kwd>vulnerability</kwd>
<kwd>precautionary principle</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="16"/>
<page-count count="2"/>
<word-count count="1597"/>
</counts>
</article-meta>
</front>
<body>
<p>In 2013, Greenbaum put forward the need to implement the Watson&#x00027;s ELSI initiative in 1988 upon the developing Genome Project (Greenbaum, <xref ref-type="bibr" rid="B5">2013</xref>). The author reviewed the efforts made up to that moment and raised a number of possible essential improvements which would require a thorough revision to ensure the success of ELSI: (A) greater involvement of professionals not directly related to genomics; (B) greater efficiency to transmit ELSI initiatives through new technologies; (C) greater independence of ELSI science funding; (D) to internationalize ELSI development integrating other visions and cultures to face the problems; (E) the need to determine precise boundaries and red lines for any research progress taking into account society&#x00027;s outlook and (F) to extend the ELSI initiative to other fields of avant-garde science.</p>
<p>Four years later after their proposal, these ideas have materialized together with certain concerns. Perhaps because reflections of professionals from non-experimental sciences and disciplines (e.g., philosophers, humanists, legislators) as well as perspectives and points of view from different cultures have been taken into account to assess the implications. In addition, ELSI science began to permeate other research disciplines showing the imperative need for red lines. In this context, it seems to us that an additional problem has aroused which is no longer related to possible poor practical application, funding, extension or its inclusive openness to other cultures of ELSI projects. Rather, it seems intrinsic to its own concept and definition: the current scope of &#x0201C;ethical,&#x0201D; &#x0201C;legal,&#x0201D; and &#x0201C;social&#x0201D; terms.</p>
<p>Greenbaum&#x00027;s essay marks the starting point of this reflection including concern and alarm: the risk to be late. This was Oliver and McGuire&#x00027;s reflection in 2011 when he demanded a faster implementation of ELSI congresses resolutions upon the fast changes in genetics without knowing whether ELSI initiatives were being truly effective (Oliver and McGuire, <xref ref-type="bibr" rid="B13">2011</xref>). The absence of an ELSI perspective in emerging research areas is also frequent (Garnett et al., <xref ref-type="bibr" rid="B3">2011</xref>) likely influenced by the lack of method and the low effectiveness of literature reviews focused on diverse directions (Walker and Morrissey, <xref ref-type="bibr" rid="B16">2014</xref>). Furthermore, a popular view of manipulation and fraud of scientific studies due to their apparent pursue of ideological (Nisbet and Markowitz, <xref ref-type="bibr" rid="B11">2014</xref>) or even economic interests (Greenbaum, <xref ref-type="bibr" rid="B5">2013</xref>) may arise. This milieu prevents a deep and balanced debate in the mass media: rather it generates information distrust and &#x0201C;media wars&#x0201D; to influence social opinion without their in-depth evaluation (McClain, <xref ref-type="bibr" rid="B9">2017</xref>). Although social networks and communication channels are extremely fast, we think that the problem strives from the public&#x00027;s capacity to understand the significance of the ELSI dilemmas. This is evidenced when ethical issues combining genomics with neuroscience, &#x0201C;<italic>neurogenomics</italic>,&#x0201D; are raised: genomic editing, gene therapy, memory manipulation, genomic identity, online communities, etc. (Canli, <xref ref-type="bibr" rid="B2">2015</xref>). All them seem to converge on a question that we think that is the big question that ELSI science must address: what is the purpose of it all? This was well evidenced in the Japanese Expert Panel on Bioethics when it assessed whether the creation of animal-human chimeras may alter the identity of human beings and therefore whether it should be allowed (Mizuno et al., <xref ref-type="bibr" rid="B10">2015</xref>). Similarly, online sharing of individual genetic features raises social issues that affect everyone as a community. Genetic makeup may be exposed in social networks with unexpected consequences: will former racism based on phenotype surface once again through a new genotype discrimination? (Hoppe, <xref ref-type="bibr" rid="B8">2013</xref>). Underlying these dilemmas we may see the apprehension upon the unknown because we do not know what we are changing. This is why it is imperative for the ELSI project to have a universal scope: local legislation is of limited use if it is permissive in another part of the globe, given the globalism of science.</p>
<p>The height of ELSI science stands out when the concept of Human Enhancement appears, whether cognitive (neuroenhancement), moral (moral enhancement), physiological (physical enhancement), genetic (genomic enhancement) or even species enhancement (transhumanism). This is illustrated with the formulation of a right to genetic improvement, is there a right not to improve? (Tamir, <xref ref-type="bibr" rid="B14">2016</xref>). From here the subsequent question follows: is there a right to be perfect? A question which has been widely debated in the context of moral enhancement (Harris and Savulescu, <xref ref-type="bibr" rid="B6">2015</xref>). The answer may be none, but with imprecise and vague reasons: we are aware that no one can force us to be better, but we do not know why (Tonkens, <xref ref-type="bibr" rid="B15">2015</xref>). There seem to exist a conceptual vacuum that causes reasoning to be stagnant, unable to define well what perfection, autonomy or identity are. At this point, O&#x00027;Connor and Nagel&#x00027;s (<xref ref-type="bibr" rid="B12">2017</xref>) emphasis or a broad concept of neuro-improvement is relevant, since any improvement initially aimed at the individual also affects society. This advocates that sometimes the solution may be relational, owing to the fact that human beings are 100% individual and social. If the driving force of human enhancement is individual interest (or individualism) it will begin to degrade and may end up perverting such initiative, due to lack holistic understanding of the relational dynamics. As Cabrera (<xref ref-type="bibr" rid="B1">2017</xref>) points out, human enhancement seems to be &#x0201C;very much about values, ideology, and political will.&#x0201D; We think that until that effort, including the purpose of the actions, is made the ELSI initiative is at risk of becoming a chimera.</p>
<p>Last, but not least, it is necessary to reflect on the precautionary principle (Gonzalvo-Cirac et al., <xref ref-type="bibr" rid="B4">2013</xref>) and its social exemplification in research settings involving society, which in itself calls for rational, cognitive and in-depth reflection (Hildt, <xref ref-type="bibr" rid="B7">2016</xref>). The problem then, becomes no longer genetic or neurological only, but moral: what do we mean as good for a human being? What is human perfection? What does it make individuals more human, regardless of being more or less intelligent, resilient or skillful? What makes an individual worthy of respect by others? How is enhancement regulated? Is science for societal good or the individual good prevails? There seem many questions which are addressed by those four words: Ethical (good), Legal (standards), Social (others), Implications (consequences) also known as ELSI science.</p>
<sec id="s1">
<title>Author contributions</title>
<p>IM and IS contributed to the discussion and writing of the manuscript.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cabrera</surname> <given-names>L. Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Reframing human enhancement: a population health perspective</article-title>. <source>Front. Sociol.</source> <volume>2</volume>:<fpage>4</fpage>. <pub-id pub-id-type="doi">10.3389/fsoc.2017.00004</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Canli</surname> <given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>Neurogenethics: an emerging discipline at the intersection of ethics, neuroscience, and genomics</article-title>. <source>Appl. Transl. Genom.</source> <volume>5</volume>, <fpage>18</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.atg.2015.05.002</pub-id><pub-id pub-id-type="pmid">26937354</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garnett</surname> <given-names>A.</given-names></name> <name><surname>Whiteley</surname> <given-names>L.</given-names></name> <name><surname>Piwowar</surname> <given-names>H.</given-names></name> <name><surname>Rasmussen</surname> <given-names>E.</given-names></name> <name><surname>Illes</surname> <given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Neuroethics and fMRI: mapping a fledgling relationship</article-title>. <source>PLoS ONE</source> <volume>6</volume>:<fpage>e18537</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0018537</pub-id><pub-id pub-id-type="pmid">21526115</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonzalvo-Cirac</surname> <given-names>M.</given-names></name> <name><surname>Roqu&#x000E9;</surname> <given-names>M. V.</given-names></name> <name><surname>Fuertes</surname> <given-names>F.</given-names></name> <name><surname>Pacheco</surname> <given-names>M.</given-names></name> <name><surname>Segarra</surname> <given-names>I.</given-names></name></person-group> (<year>2013</year>). <article-title>Is the precautionary principle adaptable to emergency scenarios to speed up research, risking the individual informed consent?</article-title> <source>Am. J. Bioethics</source> <volume>13</volume>, <fpage>17</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1080/15265161.2013.813604</pub-id><pub-id pub-id-type="pmid">23952824</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greenbaum</surname> <given-names>D.</given-names></name></person-group> (<year>2013</year>). <article-title>Grand challenge: ELSI in a changing global environment</article-title>. <source>Front. Genet.</source> <volume>4</volume>:<fpage>158</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2013.00158</pub-id><pub-id pub-id-type="pmid">23990842</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname> <given-names>J.</given-names></name> <name><surname>Savulescu</surname> <given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>A debate about moral enhancement</article-title>. <source>Camb. Q. Health Ethics</source> <volume>24</volume>, <fpage>8</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1017/S0963180114000279</pub-id><pub-id pub-id-type="pmid">25473854</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hildt</surname> <given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>Human germline interventions&#x02013;think first</article-title>. <source>Front. Genet.</source> <volume>7</volume>:<fpage>81</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2016.00081</pub-id><pub-id pub-id-type="pmid">27242891</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoppe</surname> <given-names>N.</given-names></name></person-group> (<year>2013</year>). <article-title>From omics and etics to policy and ethics: regulating evolution</article-title>. <source>Front. Genet.</source> <volume>4</volume>:<fpage>172</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2013.00172</pub-id><pub-id pub-id-type="pmid">24065981</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McClain</surname> <given-names>C. R.</given-names></name></person-group> (<year>2017</year>). <article-title>Practices and promises of Facebook for science outreach: becoming a &#x0201C;Nerd of Trust&#x0201D;</article-title>. <source>PLoS Biol.</source> <volume>15</volume>:<fpage>e2002020</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.2002020</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mizuno</surname> <given-names>H.</given-names></name> <name><surname>Akutsu</surname> <given-names>H.</given-names></name> <name><surname>Kato</surname> <given-names>K.</given-names></name></person-group> (<year>2015</year>). <article-title>Ethical acceptability of research on human-animal chimeric embryos: summary of opinions by the Japanese Expert Panel on Bioethics</article-title>. <source>Life Sci. Soc. Policy</source> <volume>11</volume>:<fpage>15</fpage>. <pub-id pub-id-type="doi">10.1186/s40504-015-0033-z</pub-id><pub-id pub-id-type="pmid">26694481</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nisbet</surname> <given-names>M.</given-names></name> <name><surname>Markowitz</surname> <given-names>E. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Understanding public opinion in debates over biomedical research: looking beyond political partisanship to focus on beliefs about science and society</article-title>. <source>PLoS ONE</source> <volume>9</volume>:<fpage>e88473</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0088473</pub-id><pub-id pub-id-type="pmid">24558393</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x00027;Connor</surname> <given-names>C.</given-names></name> <name><surname>Nagel</surname> <given-names>S. K.</given-names></name></person-group> (<year>2017</year>). <article-title>Neuro-enhancement practices across the lifecourse: exploring the roles of relationality and individualism</article-title>. <source>Front. Sociol.</source> <volume>2</volume>:<fpage>1</fpage>. <pub-id pub-id-type="doi">10.3389/fsoc.2017.00001</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oliver</surname> <given-names>J. M.</given-names></name> <name><surname>McGuire</surname> <given-names>A. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Exploring the ELSI universe: critical issues in the evolution of human genomic research</article-title>. <source>Genome Med.</source> <volume>3</volume>:<fpage>38</fpage>. <pub-id pub-id-type="doi">10.1186/gm254</pub-id><pub-id pub-id-type="pmid">21699745</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tamir</surname> <given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Postnatal human genetic enhancement&#x02013;a consideration of children&#x00027;s right to be genetically enhanced</article-title>. <source>Front. Sociol.</source> <volume>1</volume>:<fpage>15</fpage>. <pub-id pub-id-type="doi">10.3389/fsoc.2016.00015</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tonkens</surname> <given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>&#x02018;My child will never initiate ultimate harm&#x02019;: an argument against moral enhancement</article-title>. <source>J. Med. Ethics</source> <volume>41</volume>, <fpage>245</fpage>&#x02013;<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1136/medethics-2013-101855</pub-id><pub-id pub-id-type="pmid">24748649</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname> <given-names>R.</given-names></name> <name><surname>Morrissey</surname> <given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Bioethics methods in the ethical, legal, and social implications of the human genome project literature</article-title>. <source>Bioethics</source> <volume>28</volume>, <fpage>481</fpage>&#x02013;<lpage>490</lpage>. <pub-id pub-id-type="doi">10.1111/bioe.12023</pub-id><pub-id pub-id-type="pmid">23796275</pub-id></citation></ref>
</ref-list>
</back>
</article>